Module 19: Evaluation & Use of Clinical Information to Improve Patient Care - 2010
Content Expert
H. E. Davidson, PharmD
Editor-in-Chief, The Consultant Pharmacist
&
Partner
Insight Therapeutics, LLC
Disclosure
H. E. Davidson, PharmD, has no relevant financial relationship to disclose.
Course Objectives
19.01 Evidence-Based Medicine and Clinical Studies
- Define the concept of evidence-based medicine
- Explain how levels of evidence are classified
- Differentiate Type I and Type II errors of statistical interpretation
- Explain the significance of the p value and confidence intervals in interpreting clinical studies
- Describe measures of disease frequency and the use of risk and odds ratios in epidemiological studies
- Differentiate prospective and retrospective study designs in terms of their statistical effectiveness, advantages and limitations
- Cite examples of prospective and retrospective study designs
- Differentiate the features of parallel and crossover randomized controlled trials Describe the uses and principal features of multi-center study designs and meta-analyses
- Describe study designs commonly used in epidemiological studies and provide examples of each
- Define measures of disease frequency and effect commonly used in epidemiological studies
19.02 Evaluating Clinical Studies
- Define the concept of validity, and describe its significance in evaluating the quality of clinical research
- Differentiate between internal validity and external validity
- Explain how the title, abstract, and introduction for a given research study can help evaluate the quality of the information presented
- Cite criteria for evaluating the quality of the methods, results, discussion and conclusions described in a given research study
- List questions to ask when evaluating the quality of a review article
19.03 Use of Practice Guidelines
- Trace the historical development of practice guidelines, including key legislation and organizations involved
- Describe the principal intent of practice guidelines
- Describe how practice guidelines are developed
- Explain why practice guidelines are not universally implemented
- Outline proposed recommendations to making geriatric practice guidelines more readily available to clinicians
- List sources of practice guidelines
- Describe the limitations of practice guidelines, based on the method in which they were developed
19.04 Medical Use Evaluations
- Explain the purpose of medical use evaluations
- Explain the processes within the medication use system
- Describe the principal approach used to conduct medication use evaluations
- Identify criteria and related clinical indicators for the selection of drugs to be studied medication use evaluations
- Compare and contrast prospective, concurrent, and retrospective medication use evaluations
- Describe different ways in which the geriatric pharmacist can participate inmedical use evaluations
- List the kinds of data that are typically collected during a medical use evaluation
- Describe the typical structure of a medication use evaluation report
- List resources available to the geriatric pharmacist for the selection of criteria for medication use evaluations
Credit Statement
Continuing Pharmacy Education: The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity (UAN: 0203-0000-10-097-H04-P) was developed by ASCP and is approved for 1.0 Contact Hour.
This course is not approved for Florida consultant license requirements.